A significant advance in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently lost in various kinds of cancer, leading https://thebookmarkplaza.com/story21844651/mini-antibodies-revive-p53-new-potential-hope-for-tumor-management